Humana Inc. (HUM) Announces Quarterly Dividend of $0.40
Humana Inc. (NYSE:HUM) announced a quarterly dividend on Thursday, August 17th, RTT News reports. Investors of record on Tuesday, August 29th will be paid a dividend of 0.40 per share by the insurance provider on Friday, October 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.65%.
Humana has increased its dividend by an average of 3.1% annually over the last three years and has raised its dividend every year for the last 6 years. Humana has a payout ratio of 13.9% meaning its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $12.22 per share next year, which means the company should continue to be able to cover its $1.60 annual dividend with an expected future payout ratio of 13.1%.
Shares of Humana (HUM) traded up 0.12% during mid-day trading on Thursday, reaching $247.66. The company had a trading volume of 748,684 shares. The company has a market capitalization of $35.79 billion, a PE ratio of 20.37 and a beta of 0.91. Humana has a 1-year low of $163.50 and a 1-year high of $255.27. The stock’s 50-day moving average price is $240.60 and its 200 day moving average price is $224.06.
Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the prior year, the business posted $2.30 EPS. Equities analysts expect that Humana will post $11.55 EPS for the current year.
Several equities analysts recently issued reports on the company. Morgan Stanley increased their target price on Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a research note on Thursday. BidaskClub lowered Humana from a “hold” rating to a “sell” rating in a research note on Thursday. UBS AG reissued a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a research note on Wednesday, August 9th. Deutsche Bank AG increased their target price on Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $257.00 target price on shares of Humana in a research note on Friday, August 4th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $244.35.
In other news, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction on Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the sale, the vice president now owns 8,150 shares of the company’s stock, valued at $1,890,474. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP M Todoroff Christopher sold 22,935 shares of Humana stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $252.52, for a total value of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. Insiders sold a total of 41,406 shares of company stock valued at $10,355,086 over the last three months. Insiders own 0.80% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.